- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01310491
RENEWING HEALTH - RegioNs of Europe WorkINg Together for HEALTH
February 14, 2014 updated by: Tuula Karhula, South Karelia, Social and Health Care District
RENEWING HEALTH Large-scale Real-life Study in Finland
The purpose of this trial is to determine if by structured telephone based health coaching programme supported by remote monitoring system among type 2 diabetes, coronary artery disease and heart failure patients the investigators are able to improve their quality of life as measured by the SF-36 questionnaire and reduce a value of HbA1c under 6,5 % among those type 2 diabetes patients who had elevated value of HbA1c when recruited.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
RENEWING HEALTH is a project covering 9 different European States.
It aims at evaluation of innovative telemedicine services using a patient-centred approach and a common rigorous assessment methodology.
In 9 European regions in the implementation of health-related information and communication technologies service solutions are already operational at local level for the remote monitoring and the treatment of chronic patients suffering from diabetes,chronic obstructive pulmonary disease or cardiovascular diseases.
The services are designed to give patients a central role in the management of their own diseases, fine-tuning the choice and dosage of medications, promoting compliance to treatment, and helping health care professionals to detect early signs of worsening in the monitored pathologies.
Every area will designed its own real-life trial with certain common elements.
Study Type
Interventional
Enrollment (Actual)
595
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lappeenranta, Finland, 53100
- Etelä-Karjalan sosiaali- ja terveydenhuollon kuntayhtymä
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 18 years
- Capability of filling in questionnaires in Finnish language.
- Be able to use Remote Patient Monitoring System
- Be able to use the devices provided
- Has adequate cognitive capacities to participate
In their medical records, one or both of the following diagnoses:
a) Type 2 Diabetes, for enrolment
- diagnosed over 3 months prior to the enrolment and
- HbA1c > 6,5 % b) Heart Disease, for enrolment
- Ischemic heart disease or
- Heart Failure or
- Atrial fibrillation or
- Other arrhythmia
- Be able to walk
Exclusion Criteria:
- Not willing to participate (e.g., not willing to sign the consent)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care
|
Telephone based health coaching supported by tele-monitoring.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health related quality of life
Time Frame: 12 months
|
Health related quality of life is assessed by the SF-36 questionnaire.
|
12 months
|
HbA1c change over time (participants with T2DM only)
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Medication compliance
Time Frame: 12 months
|
12 months
|
Blood pressure reduction
Time Frame: 12 months
|
12 months
|
Weight reduction
Time Frame: 12 months
|
12 months
|
Activity increase
Time Frame: 12 months
|
12 months
|
Smoke cessation
Time Frame: 12 months
|
12 months
|
Alcohol use reduction
Time Frame: 12 months
|
12 months
|
Cost for the organization
Time Frame: 12 months
|
12 months
|
Satisfaction and usability of the technology and equipments.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tuula Karhula, MD, PhD, South Karelia social and health district
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
March 7, 2011
First Submitted That Met QC Criteria
March 7, 2011
First Posted (Estimate)
March 8, 2011
Study Record Updates
Last Update Posted (Estimate)
February 17, 2014
Last Update Submitted That Met QC Criteria
February 14, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Renewing Health WP WP 13 Fin
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Health coaching
-
Habit DesignUniversity of Washington; TriHealth Inc.Recruiting
-
University of California, San FranciscoKaiser PermanenteCompleted
-
Kansas State UniversityUnknown
-
Pack HealthGlaxoSmithKline; University of WashingtonRecruitingMultiple Myeloma | Relapsed Hematologic MalignancyUnited States
-
York UniversityTerminated
-
Thomas Jefferson UniversityAmerican Occupational Therapy FoundationRecruitingStroke, Acute | Caregiver Stress Syndrome | Caregiver BurnoutUnited States
-
Food and Health Bureau, Hong KongRecruiting
-
Chinese University of Hong KongRecruitingCardiovascular Diseases | Metabolic Diseases | CoachingHong Kong
-
Indonesia UniversityCompletedThe Effectiveness of "CARE Coaching Model" as an Effort to Empower Type 2 Diabetes Mellitus PatientsDiabetes Type 2Indonesia
-
University of California, Los AngelesCompletedHypertension | Obesity | Sedentary Lifestyle | PreDiabetes | Lifestyle-related ConditionUnited States